These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26464454)

  • 1. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
    Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D
    J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
    Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans.
    Ranganathan M; De Aquino JP; Cortes-Briones JA; Radhakrishnan R; Pittman B; Bhakta S; D'Souza DC
    Psychopharmacology (Berl); 2019 Nov; 236(11):3209-3219. PubMed ID: 31187152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.
    Giakoumaki SG; Roussos P; Bitsios P
    Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of Δ9-tetrahydrocannabinol (THC) on resting state connectivity networks and impact of COMT genotype: A multi-site pharmacological fMRI study.
    Pelgrim TAD; Ramaekers JG; Wall MB; Freeman TP; Bossong MG
    Drug Alcohol Depend; 2023 Oct; 251():110925. PubMed ID: 37598453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype.
    Bossong MG; van Hell HH; Schubart CD; van Saane W; Iseger TA; Jager G; van Osch MJP; Jansma JM; Kahn RS; Boks MP; Ramsey NF
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):766-776. PubMed ID: 30975584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition.
    Farrell SM; Tunbridge EM; Braeutigam S; Harrison PJ
    Biol Psychiatry; 2012 Mar; 71(6):538-44. PubMed ID: 22364739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.
    Vinkers CH; Van Gastel WA; Schubart CD; Van Eijk KR; Luykx JJ; Van Winkel R; Joëls M; Ophoff RA; Boks MP; ; Bruggeman R; Cahn W; de Haan L; Kahn RS; Meijer CJ; Myin-Germeys I; van Os J; Wiersma D
    Schizophr Res; 2013 Oct; 150(1):303-11. PubMed ID: 23954148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning.
    Morrison PD; Zois V; McKeown DA; Lee TD; Holt DW; Powell JF; Kapur S; Murray RM
    Psychol Med; 2009 Oct; 39(10):1607-16. PubMed ID: 19335936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes.
    Alemany S; Arias B; Fatjó-Vilas M; Villa H; Moya J; Ibáñez MI; Ortet G; Gastó C; Fañanás L
    Acta Psychiatr Scand; 2014 Jan; 129(1):54-62. PubMed ID: 23445265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant association between catechol-O-methyltransferase (COMT) Val
    Havelka Mestrovic A; Tudor L; Nikolac Perkovic M; Nedic Erjavec G; Kovacic Petrovic Z; Svob Strac D; Konjevod M; Pivac N
    Neurosci Lett; 2018 Feb; 666():38-43. PubMed ID: 29248614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Nieman DH; Dragt S; van Duin EDA; Denneman N; Overbeek JM; de Haan L; Rietdijk J; Ising HK; Klaassen RMC; van Amelsvoort T; Wunderink L; van der Gaag M; Linszen DH
    Schizophr Res; 2016 Jul; 174(1-3):24-28. PubMed ID: 27052366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
    Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users.
    Verdejo-García A; Fagundo AB; Cuenca A; Rodriguez J; Cuyás E; Langohr K; de Sola Llopis S; Civit E; Farré M; Peña-Casanova J; de la Torre R
    Neuropsychopharmacology; 2013 Jul; 38(8):1598-606. PubMed ID: 23449176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMT genotype, gambling activity, and cognition.
    Grant JE; Leppink EW; Redden SA; Odlaug BL; Chamberlain SR
    J Psychiatr Res; 2015 Sep; 68():371-6. PubMed ID: 26028545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
    Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
    J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
    Henquet C; Rosa A; Delespaul P; Papiol S; Fananás L; van Os J; Myin-Germeys I
    Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.